4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-022346
Chief Scientific Officer sold 6,438 shares at $55.00 ($354,090)
- Chief Scientific Officer acquired 6,438 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2017-03-20 | Option exercise | +5,933 | $9.05 | $53,694 | 21,403 | D |
| Biller Scott Chief Scientific Officer | 2017-03-20 | Sale | −5,933 | $55.00 | $326,315 | 15,470 | D |
| Biller Scott Chief Scientific Officer | 2017-03-20 | Option exercise | +505 | $0.47 | $236 | 15,975 | D |
| Biller Scott Chief Scientific Officer | 2017-03-20 | Sale | −505 | $55.00 | $27,775 | 15,470 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2017-03-20 | Option exercise · Common stock (right to buy) | −505 | 4,969 | D | ||
| Biller Scott Chief Scientific Officer | 2017-03-20 | Option exercise · Common stock (right to buy) | −5,933 | 48,157 | D | ||
| Open-market sales · 6,438 sh · avg $55.00 · $354,090 | |||||||
Loading xslF345X03/doc4.xml…